The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and acquired neuromyotonia
Open accessAbstract
Antibodies that immunoprecipitate (125)I-alpha-dendrotoxin-labelled voltage-gated potassium channels extracted from mammalian brain tissue have been identified in patients with neuromyotonia, Morvan's syndrome, limbic encephalitis and a few cases of adult-onset epilepsy. These conditions often improve following immunomodulatory therapies. However, the proportions of the different syndromes, the numbers with associated tumours and the relationships with potassium channel subunit antibody specificities have been unclear. We documented the clinical phenotype and tumour associations in 96 potassium channel antibody positive patients (titres >400 pM). Five had thymomas and one had an endometrial adenocarcinoma. To define the antibody specificities, we looked for binding of serum antibodies and their effects on potassium channel currents using human embryonic kidney cells expressing the potassium channel subunits. Surprisingly, only three of the patients had antibodies directed against the potassium channel subunits. By contrast, we found antibodies to three proteins that are complexed with (125)I-alpha-dendrotoxin-labelled potassium channels in brain extracts: (i) contactin-associated protein-2 that is localized at the juxtaparanodes in myelinated axons; (ii) leucine-rich, glioma inactivated 1 protein that is most strongly expressed in the hippocampus; and (iii) Tag-1/contactin-2 that associates with contactin-associated protein-2. Antibodies to Kv1 subunits were found in three sera, to contactin-associated protein-2 in 19 sera, to leucine-rich, glioma inactivated 1 protein in 55 sera and to contactin-2 in five sera, four of which were also positive for the other antibodies. The remaining 18 sera were negative for potassium channel subunits and associated proteins by the methods employed. Of the 19 patients with contactin-associated protein-antibody-2, 10 had neuromyotonia or Morvan's syndrome, compared with only 3 of the 55 leucine-rich, glioma inactivated 1 protein-antibody positive patients (P < 0.0001), who predominantly had limbic encephalitis. The responses to immunomodulatory therapies, defined by changes in modified Rankin scores, were good except in the patients with tumours, who all had contactin-associated-2 protein antibodies. This study confirms that the majority of patients with high potassium channel antibodies have limbic encephalitis without tumours. The identification of leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 as the major targets of potassium channel antibodies, and their associations with different clinical features, begins to explain the diversity of these syndromes; furthermore, detection of contactin-associated protein-2 antibodies should help identify the risk of an underlying tumour and a poor prognosis in future patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lai, M., Huijbers, M. G., Lancaster, E., Graus, F., Bataller, L., Balice-Gordon, R., Cowell, J. K., & Dalmau, J. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70137-x · Cited by 1,361
Vincent, A., Buckley, C., Schott, J. M., Baker, I., Dewar, B., Detert, N., Clover, L., Parkinson, A., Bien, C. G., Omer, S., et al. (2004) · Brain · doi:10.1093/brain/awh077 · Cited by 1,038
Self-citationIrani, S. R., Bera, K., Waters, P., Zuliani, L., Maxwell, S., Zandi, M. S., Friese, M. A., Galea, I., Kullmann, D. M., Beeson, D., et al. (2010) · Brain · doi:10.1093/brain/awq113 · Cited by 1,035 · cited 2×
“Details on tissues and binding of the serum antibodies to live neurons in culture are provided in the Supplementary Methods and in Irani et al. (2010).”
Self-citationAnti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients
Graus, F. (2001) · Brain · doi:10.1093/brain/124.6.1138 · Cited by 897
Paraneoplastic syndromes of the CNS
Dalmau, J., & Rosenfeld, M. R. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70060-7 · Cited by 873
Recessive symptomatic focal epilepsy and mutant contactin-associated protein-like 2
Strauss, K. A., Puffenberger, E. G., Huentelman, M. J., Gottlieb, S., Dobrin, S. E., Parod, J. M., Stephan, D. A., & Morton, D. H. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052773 · Cited by 630
Juxtaparanodal clustering of Shaker-like K+ channels in myelinated axons depends on Caspr2 and TAG-1
Poliak, S., Salomon, D., Elhanany, H., Sabanay, H., Kiernan, B., Pevny, L., Stewart, C. L., Xu, X., Chiu, S.-Y., Shrager, P., et al. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200305018 · Cited by 564
Self-citationIgG1 antibodies to acetylcholine receptors in ‘seronegative’ myasthenia gravis†
Leite, M. I., Jacob, S., Viegas, S., Cossins, J., Clover, L., Morgan, B. P., Beeson, D., Willcox, N., & Vincent, A. (2008) · Brain · doi:10.1093/brain/awn092 · Cited by 527
Self-citationPoliak, S., Gollan, L., Martinez, R., Custer, A., Einheber, S., Salzer, J. L., Trimmer, J. S., Shrager, P., & Peles, E. (1999) · Neuron · doi:10.1016/s0896-6273(00)81049-1 · Cited by 526
Self-citationTreatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates
Ances, B. M., Vitaliani, R., Taylor, R. A., Liebeskind, D. S., Voloschin, A., Houghton, D. J., Galetta, S. L., Dichter, M., Alavi, A., Rosenfeld, M. R., et al. (2005) · Brain · doi:10.1093/brain/awh526 · Cited by 488
Cited by
A clinical approach to diagnosis of autoimmune encephalitis
Graus, F., Titulaer, M. J., Balu, R., Benseler, S., Bien, C. G., Cellucci, T., Cortese, I., Dale, R. C., Gelfand, J. M., Geschwind, M., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00401-9 · Cited by 4,516
Self-citationClinical experience and laboratory investigations in patients with anti-NMDAR encephalitis
Dalmau, J., Lancaster, E., Martinez-Hernandez, E., Rosenfeld, M. R., & Balice-Gordon, R. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70253-2 · Cited by 2,435
Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis
Irani, S. R., Michell, A. W., Lang, B., Pettingill, P., Waters, P., Johnson, M. R., Schott, J. M., Armstrong, R. J. E., S. Zagami, A., Bleasel, A., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22307 · Cited by 928
Self-citationMoshé, S. L., Perucca, E., Ryvlin, P., & Tomson, T. (2015) · The Lancet · doi:10.1016/s0140-6736(14)60456-6 · Cited by 905
Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia
Lancaster, E., Huijbers, M. G. M., Bar, V., Boronat, A., Wong, A., Martinez‐Hernandez, E., Wilson, C., Jacobs, D., Lai, M., Walker, R. W., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22297 · Cited by 737
Self-citationImmunopathology of autoantibody-associated encephalitides: clues for pathogenesis
Bien, C. G., Vincent, A., Barnett, M. H., Becker, A. J., Blumcke, I., Graus, F., Jellinger, K. A., Reuss, D. E., Ribalta, T., Schlegel, J., et al. (2012) · Brain · doi:10.1093/brain/aws082 · Cited by 695
Self-citationAnti-LGI1 encephalitis: Clinical syndrome and long-term follow-up
van Sonderen, A., Thijs, R. D., Coenders, E. C., Jiskoot, L. C., Sanchez, E., de Bruijn, M. A. A. M., van Coevorden-Hameete, M. H., Wirtz, P. W., Schreurs, M. W. J., Sillevis Smitt, P. A. E., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000003173 · Cited by 658
Dalmau, J., Geis, C., & Graus, F. (2017) · Physiological Reviews · doi:10.1152/physrev.00010.2016 · Cited by 628
Petit-Pedrol, M., Armangue, T., Peng, X., Bataller, L., Cellucci, T., Davis, R., McCracken, L., Martinez-Hernandez, E., Mason, W. P., Kruer, M. C., et al. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70299-0 · Cited by 616
Autoantibodies associated with diseases of the CNS: new developments and future challenges
Vincent, A., Bien, C. G., Irani, S. R., & Waters, P. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70096-5 · Cited by 542
Self-citationMorvan syndrome: Clinical and serological observations in 29 cases
Irani, S. R., Pettingill, P., Kleopa, K. A., Schiza, N., Waters, P., Mazia, C., Zuliani, L., Watanabe, O., Lang, B., Buckley, C., et al. (2012) · Annals of Neurology · doi:10.1002/ana.23577 · Cited by 540
Self-citationScreening for tumours in paraneoplastic syndromes: report of an EFNS Task Force
Titulaer, M. J., Soffietti, R., Dalmau, J., Gilhus, N. E., Giometto, B., Graus, F., Grisold, W., Honnorat, J., Sillevis Smitt, P. A. E., Tanasescu, R., et al. (2011) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.03220.x · Cited by 526
Infections, inflammation and epilepsy
Vezzani, A., Fujinami, R. S., White, H. S., Preux, P.-M., Blümcke, I., Sander, J. W., & Löscher, W. (2016) · Acta Neuropathologica · doi:10.1007/s00401-015-1481-5 · Cited by 518
Neuronal autoantigens—pathogenesis, associated disorders and antibody testing
Lancaster, E., & Dalmau, J. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.99 · Cited by 512
Solomon, T., Michael, B. D., Smith, P. E., Sanderson, F., Davies, N. W. S., Hart, I. J., Holland, M., Easton, A., Buckley, C., Kneen, R., et al. (2012) · Journal of Infection · doi:10.1016/j.jinf.2011.11.014 · Cited by 464
Self-citationThe clinical spectrum of Caspr2 antibody–associated disease
van Sonderen, A., Ariño, H., Petit-Pedrol, M., Leypoldt, F., Körtvélyessy, P., Wandinger, K.-P., Lancaster, E., Wirtz, P. W., Schreurs, M. W. J., Sillevis Smitt, P. A. E., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000002917 · Cited by 441
Irani, S. R., Stagg, C. J., Schott, J. M., Rosenthal, C. R., Schneider, S. A., Pettingill, P., Pettingill, R., Waters, P., Thomas, A., Voets, N. L., et al. (2013) · Brain · doi:10.1093/brain/awt212 · Cited by 437
Self-citationThe Diagnosis and Treatment of Autoimmune Encephalitis
Lancaster, E. (2016) · Journal of Clinical Neurology · doi:10.3988/jcn.2016.12.1.1 · Cited by 437
Leypoldt, F., Armangue, T., & Dalmau, J. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12553 · Cited by 416
Encephalitis and antibodies to synaptic and neuronal cell surface proteins
Lancaster, E., Martinez-Hernandez, E., & Dalmau, J. (2011) · Neurology · doi:10.1212/wnl.0b013e318224afde · Cited by 403
Pollak, T. A., Lennox, B. R., Müller, S., Benros, M. E., Prüss, H., Tebartz van Elst, L., Klein, H., Steiner, J., Frodl, T., Bogerts, B., et al. (2020) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30290-1 · Cited by 402
Self-citationAntibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders
Dale, R. C., Merheb, V., Pillai, S., Wang, D., Cantrill, L., Murphy, T. K., Ben-Pazi, H., Varadkar, S., Aumann, T. D., Horne, M. K., et al. (2012) · Brain · doi:10.1093/brain/aws256 · Cited by 388
Encephalitis and AMPA receptor antibodies: Novel findings in a case series of 22 patients
Höftberger, R., van Sonderen, A., Leypoldt, F., Houghton, D., Geschwind, M., Gelfand, J., Paredes, M., Sabater, L., Saiz, A., Titulaer, M. J., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001682 · Cited by 382
Clinical approach to the diagnosis of autoimmune encephalitis in the pediatric patient
Cellucci, T., Van Mater, H., Graus, F., Muscal, E., Gallentine, W., Klein-Gitelman, M. S., Benseler, S. M., Frankovich, J., Gorman, M. P., Van Haren, K., et al. (2020) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000663 · Cited by 373
Boronat, A., Gelfand, J. M., Gresa‐Arribas, N., Jeong, H., Walsh, M., Roberts, K., Martinez‐Hernandez, E., Rosenfeld, M. R., Balice‐Gordon, R., Graus, F., et al. (2013) · Annals of Neurology · doi:10.1002/ana.23756 · Cited by 373
Autoimmune Epilepsy: Clinical Characteristics and Response to Immunotherapy
Quek, A. M. L. (2012) · Archives of Neurology · doi:10.1001/archneurol.2011.2985 · Cited by 359
Ohkawa, T., Fukata, Y., Yamasaki, M., Miyazaki, T., Yokoi, N., Takashima, H., Watanabe, M., Watanabe, O., & Fukata, M. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.3506-13.2013 · Cited by 357
Seroprevalence of autoantibodies against brain antigens in health and disease
Dahm, L., Ott, C., Steiner, J., Stepniak, B., Teegen, B., Saschenbrecker, S., Hammer, C., Borowski, K., Begemann, M., Lemke, S., et al. (2014) · Annals of Neurology · doi:10.1002/ana.24189 · Cited by 350
Anti-LGI1–associated cognitive impairment: Presentation and long-term outcome
Ariño, H., Armangué, T., Petit-Pedrol, M., Sabater, L., Martinez-Hernandez, E., Hara, M., Lancaster, E., Saiz, A., Dalmau, J., & Graus, F. (2016) · Neurology · doi:10.1212/wnl.0000000000003009 · Cited by 348
B cells in autoimmune and neurodegenerative central nervous system diseases
Sabatino, J. J., Pröbstel, A.-K., & Zamvil, S. S. (2019) · Nature Reviews Neuroscience · doi:10.1038/s41583-019-0233-2 · Cited by 343
Disrupted surface cross-talk between NMDA and Ephrin-B2 receptors in anti-NMDA encephalitis
Mikasova, L., De Rossi, P., Bouchet, D., Georges, F., Rogemond, V., Didelot, A., Meissirel, C., Honnorat, J., & Groc, L. (2012) · Brain · doi:10.1093/brain/aws092 · Cited by 341
Opening paths to novel analgesics: the role of potassium channels in chronic pain
Tsantoulas, C., & McMahon, S. B. (2014) · Trends in Neurosciences · doi:10.1016/j.tins.2013.12.002 · Cited by 322
Autoantibodies in neurological disease
Prüss, H. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-021-00543-w · Cited by 319
Finke, C., Prüss, H., Heine, J., Reuter, S., Kopp, U. A., Wegner, F., Then Bergh, F., Koch, S., Jansen, O., Münte, T., et al. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2016.4226 · Cited by 318
Autoimmune Encephalitis: Pathophysiology and Imaging Review of an Overlooked Diagnosis
Kelley, B. P., Patel, S. C., Marin, H. L., Corrigan, J. J., Mitsias, P. D., & Griffith, B. (2017) · American Journal of Neuroradiology · doi:10.3174/ajnr.a5086 · Cited by 310
Autoimmune Encephalitis Misdiagnosis in Adults
Flanagan, E. P., Geschwind, M. D., Lopez-Chiriboga, A. S., Blackburn, K. M., Turaga, S., Binks, S., Zitser, J., Gelfand, J. M., Day, G. S., Dunham, S. R., et al. (2023) · JAMA Neurology · doi:10.1001/jamaneurol.2022.4251 · Cited by 303
Self-citationManford, M. (2017) · Journal of Neurology · doi:10.1007/s00415-017-8394-2 · Cited by 299
Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica
Waters, P., Reindl, M., Saiz, A., Schanda, K., Tuller, F., Kral, V., Nytrova, P., Sobek, O., Nielsen, H. H., Barington, T., et al. (2016) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2015-312601 · Cited by 294
Self-citationZuliani, L., Graus, F., Giometto, B., Bien, C., & Vincent, A. (2012) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-301237 · Cited by 293
Self-citationDe novo loss- or gain-of-function mutations in KCNA2 cause epileptic encephalopathy
EuroEPINOMICS, R. E. S., Syrbe, S., Hedrich, U. B. S., Riesch, E., Djémié, T., Müller, S., Møller, R. S., Maher, B., Hernandez-Hernandez, L., Synofzik, M., et al. (2015) · Nature Genetics · doi:10.1038/ng.3239 · Cited by 276
The value of LGI1, Caspr2 and voltage-gated potassium channel antibodies in encephalitis
van Sonderen, A., Petit-Pedrol, M., Dalmau, J., & Titulaer, M. J. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.43 · Cited by 272
Imaging of autoimmune encephalitis – Relevance for clinical practice and hippocampal function
Heine, J., Prüss, H., Bartsch, T., Ploner, C. J., Paul, F., & Finke, C. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.05.037 · Cited by 272
Hacohen, Y., Wright, S., Waters, P., Agrawal, S., Carr, L., Cross, H., De Sousa, C., DeVile, C., Fallon, P., Gupta, R., et al. (2013) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-303807 · Cited by 269
Self-citationTargeting the neural extracellular matrix in neurological disorders
Soleman, S., Filippov, M. A., Dityatev, A., & Fawcett, J. W. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.08.050 · Cited by 244
The Emerging Link Between Autoimmune Disorders and Neuropsychiatric Disease
Kayser, M. S., & Dalmau, J. (2011) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.23.1.90 · Cited by 133
Two Classes of Secreted Synaptic Organizers in the Central Nervous System
Yuzaki, M. (2018) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021317-121322 · Cited by 125
Fukata, Y., Chen, X., Chiken, S., Hirano, Y., Yamagata, A., Inahashi, H., Sanbo, M., Sano, H., Goto, T., Hirabayashi, M., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2022580118 · Cited by 91
Pathogen and Antibody Identification in Children with Encephalitis in Myanmar
Galardi, M. M., Sowa, G. M., Crockett, C. D., Rudock, R., Smith, A. E., Shwe, E. E., San, T., Linn, K., Aye, A. M. M., Ramachandran, P. S., et al. (2023) · Annals of Neurology · doi:10.1002/ana.26560 · Cited by 14
Metadata
- Authors
- Irani, S. R., Alexander, S., Waters, P., Kleopa, K. A., Pettingill, P., Zuliani, L., Peles, E., Buckley, C., Lang, B., & Vincent, A.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-07-27
- Volume
- 133
- Issue
- 9
- Pages
- 2734-2748
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2100252544
- Cited by
- 1,359
- References
- 34
- FWCI
- 42.72
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.